» Authors » Emmanuel Thomas

Emmanuel Thomas

Explore the profile of Emmanuel Thomas including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 70
Citations 1308
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Seetharam D, Chandar J, Ramsoomair C, Desgraves J, Medina A, Hudson A, et al.
bioRxiv . 2024 Oct; PMID: 39464150
Viral mimicry refers to the activation of innate anti-viral immune responses due to the induction of endogenous retroelement (RE) expression. Viral mimicry has been previously described to augment anti-tumor immune...
2.
Abu Y, Huang B, Thomas E, Lang D, Ferreira T, Estes K, et al.
AIDS Patient Care STDS . 2024 Aug; 38(8):344-347. PMID: 39158978
No abstract available.
3.
Cook R, Richards V, Gullett J, Lerner B, Zhou Z, Porges E, et al.
JMIR Res Protoc . 2024 Apr; 13:e53684. PMID: 38564243
Background: Both alcohol consumption and HIV infection are associated with worse brain, cognitive, and clinical outcomes in older adults. However, the extent to which brain and cognitive dysfunction is reversible...
4.
McDuffie D, Alver C, Suthar B, Helm M, Oliver D, Burgess R, et al.
Lab Chip . 2023 Jun; 23(13):3106-3119. PMID: 37313651
Microphysiological Systems (MPSs) or organs-on-chips, are microfluidic devices used to model human physiology . Polydimethylsiloxane (PDMS) is the most widely used material for organs-on-chips due to its established fabrication methods...
5.
Martinez A, Cheng W, Marx S, Manthena S, Dylla D, Wilson L, et al.
Adv Ther . 2023 Jun; 40(8):3465-3477. PMID: 37285080
Introduction: Direct-acting antiviral (DAA) therapy is highly effective in curing hepatitis C virus (HCV) infection in people who inject drugs (PWID). Previous studies showed declining persistence to DAA therapy over...
6.
Carattini Y, Griswold A, Williams S, Valiathan R, Zhou Y, Shukla B, et al.
Viruses . 2023 Mar; 15(3). PMID: 36992302
Over the course of the COVID-19 pandemic, SARS-CoV-2 variants of concern (VOCs) with increased transmissibility and immune escape capabilities, such as Delta and Omicron, have triggered waves of new COVID-19...
7.
Edwards J, Delabat S, Badilla A, DiCaprio R, Hyun J, Burgess R, et al.
JHEP Rep . 2022 Nov; 4(12):100592. PMID: 36439639
Background & Aims: Increased expression of IFN-stimulated gene 15 (ISG15) and subsequently increased ISGylation are key factors in the host response to viral infection. In this study, we sought to...
8.
McDuffie D, Barr D, Helm M, Baumert T, Agarwal A, Thomas E
Semin Liver Dis . 2022 Nov; 43(1):31-49. PMID: 36402129
Viral hepatitis is a leading cause of liver morbidity and mortality globally. The mechanisms underlying acute infection and clearance, versus the development of chronic infection, are poorly understood. In vitro...
9.
Thomas E
Gastroenterol Hepatol (N Y) . 2022 Nov; 18(6):333-336. PMID: 36398139
No abstract available.
10.
McDuffie D, Barr D, Agarwal A, Thomas E
Front Microbiol . 2022 Oct; 13():999366. PMID: 36246284
Viral hepatitis is a leading cause of liver disease and mortality. Infection can occur acutely or chronically, but the mechanisms that govern the clearance of virus or lack thereof are...